Sarepta Therapeutics Inc (NASDAQ:SRPT)

CAPS Rating: 3 out of 5

A biopharmaceutical company developing therapeutic products principally based on third-generation NEUGENE antisense technology.

Recs

0
Player Avatar StockTraderG (82.92) Submitted: 10/3/2012 11:49:09 AM : Outperform Start Price: $15.36 SRPT Score: +91.85

Big Data coming

Member Avatar jc07 (50.01) Submitted: 10/5/2012 10:12:29 AM
Recs: 0

This man is a wizard

Featured Broker Partners


Advertisement